Manager, Enterprise Stewardship & Standards
Regeneron Pharmaceuticals
Summary
The Manager, Enterprise Stewardship & Standards maintains and updates the foundational semantic and accountability layer of the enterprise data stewardship function. This role maintains the enterprise glossary and canonical definitions for cross-domain planning concepts, updates the business rules governing shared planning data, and helps maintain steward and data-owner accountability through RACI alignment.
Job description
Discover your role
- Maintain and update the enterprise glossary and canonical definitions for cross-domain planning concepts (e.g., study, program, milestone, resource, and financial terms), ensuring a single consistent definition is used across systems, functions, and reports.
- Maintain and update business-rule documentation for shared planning data, partnering with domain subject-matter experts to validate rule accuracy, ownership, and version history.
- Maintain and update existing RACI matrices that clarify steward and data-owner roles across domains, ensuring accountability for definitions, quality, and lifecycle management is explicit, current, and communicated.
- Co-facilitate recurring cross-functional working forums alongside the Director, Data Stewardship - independently leading smaller or more routine working sessions - that bring together domain owners, Business Process Owners, and stewardship partners to reach alignment on definitions, standards, and business rules.
- Prepare decision records and escalation packages – summarizing the issue, options considered, and collaborator positions – and route unresolved cross-domain conflicts to the Director, Data Stewardship or relevant governance body for resolution.
- Partner with Data Governance to ensure the glossary, canonical definitions, and business rules align with enterprise-wide data policies, standards, and SOPs.
- Collaborate with system Business Process Owners (e.g., Planisware, Planview) and Program, Portfolio Management, and Project Planning leads to ensure standards and definitions reflect planning-system requirements and terminology.
- Support DADS (Data Analytics & Data Science) by ensuring canonical definitions and business rules are correctly and consistently reflected in enterprise analytics, data products, and AI/ML initiatives.
- Track and report on glossary coverage, standards adoption, and forum outcomes, providing input to the broader stewardship roadmap and operating-model maturity.
- Maintain a system of record for definitions, RACI assignments, decision records, and escalation history to support auditability and knowledge continuity.
This role requires
- Solid understanding of drug development, clinical/program planning, and portfolio management terminology and processes.
- Demonstrated experience developing and governing business glossaries, canonical data definitions, and business-rule documentation, ideally within a data governance or data management framework.
- Skilled in developing RACI matrices and clarifying roles and accountabilities across cross-functional stakeholder groups.
- Strong meeting facilitation skills, with a proven ability to drive alignment among stakeholders with competing priorities and to manage conflict constructively.
- Excellent written communication skills, including the ability to produce clear, concise decision records and escalation packages for senior audiences.
- Familiarity with project planning and analytics tools such as Planisware, Planview, Microsoft Project, and Microsoft Office (Word, Excel, PowerPoint).
- Strong analytical and problem-solving skills, with close attention to detail and consistency across data definitions.
- Ability to work collaboratively in a matrixed organization, under the guidance and direction of the Director, Data Stewardship, partnering with Data Governance, DADS, Business Process Owners, and domain data stewards.
- Experience with data governance / business glossary tools (e.g., Collibra, Alation) is a plus.
- Data management or governance certification (e.g., CDMP) and/or PMI Project Management Professional (PMP) is preferred but not required.
- 5+ years in data management, data governance, business analysis, or related roles, within the biotechnology, pharmaceutical, or health-related industry, including experience facilitating cross-functional alignment on data definitions and standards.
Location: Tarrytown NY, or Warren NJ. Travel percentage: 10%.
Requirements
- Bachelor's Degree or equivalent experience in a related field
- At least 5 or more years of experience in the biotechnology, pharmaceutical, or health-related industry
- Solid understanding of drug development, clinical/program planning, and portfolio management terminology and processes
- Demonstrated experience developing and governing business glossaries, canonical data definitions, and business-rule documentation
- Skilled in developing RACI matrices and clarifying roles and accountabilities across cross-functional stakeholder groups
- Strong meeting facilitation skills and ability to manage conflict constructively
- Excellent written communication skills
- Familiarity with project planning and analytics tools such as Planisware, Planview, Microsoft Project, and Microsoft Office
- Strong analytical and problem-solving skills with attention to detail
- Ability to work collaboratively in a matrixed organization
- 5+ years in data management, data governance, business analysis, or related roles within the biotechnology, pharmaceutical, or health-related industry
- Experience with data governance / business glossary tools (e.g., Collibra, Alation) is a plus
- Data management or governance certification (e.g., CDMP) and/or PMP is preferred but not required
Benefits
- Annual bonuses
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.